{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:43:43Z","timestamp":1791351823137,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1002\/jps.20157","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T18:01:18Z","timestamp":1090605678000},"page":"2458-2475","source":"Crossref","is-referenced-by-count":150,"title":["Development of stable liquid formulations for adenovirus-based vaccines"],"prefix":"10.1016","volume":"93","author":[{"given":"Robert K.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise K.","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne A.","family":"Isopi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo R.","family":"Casimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Shiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Volkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20157_bb0010","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3181\/00379727-112-28201","article-title":"Effect of pH on thermal stabilization of oral poliovirus vaccine by magnesium chloride","volume":"112","author":"Melnick","year":"1963","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1002\/jps.20157_bb0015","first-page":"465","article-title":"Inadequate poliovirus immunity levels in Illinois children","volume":"126","author":"Rasmussen","year":"1973","journal-title":"Am J Dis Child"},{"key":"10.1002\/jps.20157_bb0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0264-410X(00)00124-9","article-title":"Stabilization of vaccines: To be or not to be","volume":"19","author":"Arya","year":"2001","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1002\/jps.20157_bb0025","doi-asserted-by":"crossref","first-page":"S613","DOI":"10.1093\/clinids\/11.Supplement_3.S613","article-title":"Improving the heat stability of vaccines: Problems, needs, and approaches","volume":"11","author":"Hilleman","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1002\/jps.20157_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0266462300014100","article-title":"The thermostability of vaccines","volume":"10","author":"Lemon","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1002\/jps.20157_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/scientificamerican1076-25","article-title":"The eradication of smallpox","volume":"235","author":"Henderson","year":"1976","journal-title":"Sci Am"},{"key":"10.1002\/jps.20157_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/viro.2000.0208","article-title":"Eradication of polio by vaccination","volume":"268","author":"Minor","year":"2000","journal-title":"Virology"},{"key":"10.1002\/jps.20157_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1556\/AMicr.48.2001.3-4.6","article-title":"Recombinant adenovirus vectors for gene therapy and clinical trials (a review)","volume":"48","author":"Nasz","year":"2001","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1002\/jps.20157_bb0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0264-410X(95)00032-V","article-title":"Adenovirus vectors as recombinant viral vaccines","volume":"13","author":"Imler","year":"1995","journal-title":"Vaccine"},{"key":"10.1002\/jps.20157_bb0055","first-page":"45","article-title":"Adenovirus recombinants as vehicles for AIDS vaccine development","volume":"1","author":"Peng","year":"1999","journal-title":"Curr Topics Virol"},{"key":"10.1002\/jps.20157_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/10837459809009865","article-title":"Factors that influence the stability of recombinant adenoviral preparations for human gene therapy","volume":"3","author":"Croyle","year":"1998","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.20157_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12665\/J11.Sosnowski","article-title":"Development of a stable adenoviral vector formulation","volume":"1","author":"Hoganson","year":"2002","journal-title":"Bioprocessing: Tech Dev Opp"},{"key":"10.1002\/jps.20157_bb0070","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/10430340050111368","article-title":"Development of a rapid method for PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions","volume":"11","author":"Croyle","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jps.20157_bb0075","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","article-title":"Development of formulations that enhance physical stability of viral vectors for gene therapy","volume":"8","author":"Croyle","year":"2001","journal-title":"Gene Ther"},{"key":"10.1002\/jps.20157_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-0934(02)00028-9","article-title":"Preparation of purified, sterilized, and stable adenovirus vectors using albumin","volume":"103","author":"Hosokawa","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1002\/jps.20157_bb0085","series-title":"Formulation of adenovirus for gene therapy","author":"Wu","year":"2002"},{"key":"10.1002\/jps.20157_bb0090","series-title":"Composition for the preservation of viruses","author":"Setiawan","year":"2003"},{"key":"10.1002\/jps.20157_bb0095","series-title":"Compositions comprising viruses and methods for concentrating virus preparations","author":"Frei","year":"2003"},{"key":"10.1002\/jps.20157_bb0100","series-title":"Composition and method for maintaining non-enveloped viral vectors","author":"Kovesdi","year":"2003"},{"key":"10.1002\/jps.20157_bb0105","series-title":"Composition for the preservation of infectious recombinant adenoviruses","author":"Blanche","year":"2000"},{"key":"10.1002\/jps.20157_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abio.2001.5210","article-title":"Stabilization of recombinant adenovirus: Site-directed mutagenesis of key asparagine residues in the hexon protein","volume":"297","author":"Blanche","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1002\/jps.20157_bb0115","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1128\/JVI.77.13.7663-7668.2003","article-title":"Vaccine-induced immunity in baboons using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol"},{"key":"10.1002\/jps.20157_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"10.1002\/jps.20157_bb0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260nm under conditions of complete DNA disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"key":"10.1002\/jps.20157_bb0130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/ac60214a047","article-title":"Smoothing and differentiation by simplified least squares procedures","volume":"36","author":"Savitzky","year":"1964","journal-title":"Anal Chem"},{"key":"10.1002\/jps.20157_bb0135","unstructured":"Wang F, Puddy AC, Louis AA, McMackin JL, Xu J, Mathis B, Zhang Y, Tan CY,Schofield TL, Wolf JJ, Lewis JA. The application of QPCR to assign potencies to adenovirus based vaccines and vectors for gene therapy: A general approach for automated virus potency testing. In preparation."},{"key":"10.1002\/jps.20157_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/10430340360464688","article-title":"Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens","volume":"14","author":"Wang","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jps.20157_bb0145","series-title":"Probit analysis: Statistical treatment of the sigmoid response curve","author":"Finney","year":"1964"},{"key":"10.1002\/jps.20157_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/JVI.76.1.185-194.2002","article-title":"Vaccine-induced immune responses in rodents and non-human primates by use of a humanized HIV-1 pol gene","volume":"76","author":"Casimiro","year":"2002","journal-title":"J Virol"},{"key":"10.1002\/jps.20157_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000149363","article-title":"Biological and structural studies with an adenovirus type 2 temperature-sensitive mutant defective for uncoating","volume":"19","author":"Hannan","year":"1983","journal-title":"Intervirology"},{"key":"10.1002\/jps.20157_bb0160","series-title":"Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine","author":"Sene","year":"1998"},{"key":"10.1002\/jps.20157_bb0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/bit.260480511","article-title":"Chemical instability of protein pharmaceuticals: Mechanism of oxidation and strategies for stabilization","volume":"48","author":"Li","year":"1995","journal-title":"Biotechnol Bioeng"},{"key":"10.1002\/jps.20157_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<76::AID-JPS8>3.0.CO;2-U","article-title":"Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies","volume":"89","author":"Evans","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20157_bb0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1039\/CT8946500899","article-title":"Oxidation of tartaric acid in the presence of iron","volume":"65","author":"Fenton","year":"1894","journal-title":"J Chem Soc"},{"key":"10.1002\/jps.20157_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/03639049809085598","article-title":"Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage","volume":"24","author":"Nelson","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.20157_bb0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0955-2863(98)00022-9","article-title":"Antioxidant characteristics of L-histidine","volume":"9","author":"Wade","year":"1998","journal-title":"J Nutr Biochem"},{"key":"10.1002\/jps.20157_bb0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jps.10340","article-title":"Structural stability of adenovirus type-5","volume":"92","author":"Rexroad","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20157_bb0195","first-page":"1","article-title":"Formulation, stability, and delivery of live attenuated vaccines for human use","volume":"16","author":"Burke","year":"1999","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.20157_bb0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0928-0987(99)00059-7","article-title":"In vitro investigation of the effect of various isotonic substances in parenteral emulsions on human erythrocytes","volume":"9","author":"Jumaa","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20157_bb0205","series-title":"Remmington: The science and practice of pharmacy, 19th ed","first-page":"613","article-title":"Tonicity, osmoticity, osmolality and osmolarity","author":"Reich","year":"1995"},{"key":"10.1002\/jps.20157_bb0210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0960-9822(00)00176-7","article-title":"Structures of poliovirus complexes with anti-viral drugs: Implications for viral stability and drug design","volume":"4","author":"Grant","year":"1994","journal-title":"Curr Biol"},{"key":"10.1002\/jps.20157_bb0215","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1128\/JVI.68.5.3397-3400.1994","article-title":"Discrepancy between infectivity and antigenicity stabilization of oral poliovaccine by a capsid-binding compound","volume":"68","author":"Andries","year":"1994","journal-title":"J Virol"},{"key":"10.1002\/jps.20157_bb0220","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/JVI.68.10.6454-6457.1994","article-title":"Thermal inactivation of oral polio vaccine: Contribution of RNA and protein inactivation","volume":"68","author":"Rombaut","year":"1994","journal-title":"J Virol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916316173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916316173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:08:35Z","timestamp":1585847315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916316173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0022354916316173"],"URL":"https:\/\/doi.org\/10.1002\/jps.20157","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}